Eirini Vasarmidi

1.4k total citations · 1 hit paper
40 papers, 833 citations indexed

About

Eirini Vasarmidi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Eirini Vasarmidi has authored 40 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 9 papers in Rheumatology. Recurrent topics in Eirini Vasarmidi's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers), Eosinophilic Disorders and Syndromes (8 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Eirini Vasarmidi is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers), Eosinophilic Disorders and Syndromes (8 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Eirini Vasarmidi collaborates with scholars based in Greece, United Kingdom and France. Eirini Vasarmidi's co-authors include Κατερίνα Αντωνίου, George Margaritopoulos, Eliza Tsitoura, Νikolaos Tzanakis, Demetrios�� Spandidos, Athina Trachalaki, Eleni Bibaki, Athol U. Wells, Nikos Tzanakis and Joseph Jacob and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Frontiers in Immunology and European Respiratory Journal.

In The Last Decade

Eirini Vasarmidi

36 papers receiving 826 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Respiratory Society statement on long COVID follow-up

2022 102 citations Κατερίνα Αντωνίου, Eirini Vasarmidi et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eirini Vasarmidi Greece	14	541	212	168	117	116	40	833
Benjamin Garfield United Kingdom	12	257 0.5×	132 0.6×	124 0.7×	185 1.6×	166 1.4×	26	686
Angelantonio Maglio Italy	15	230 0.4×	85 0.4×	141 0.8×	151 1.3×	298 2.6×	38	682
Hideki Yasui Japan	21	777 1.4×	147 0.7×	47 0.3×	58 0.5×	366 3.2×	113	1.2k
Gael B. Morrow United Kingdom	10	126 0.2×	75 0.4×	95 0.6×	201 1.7×	24 0.2×	17	509
Wenqing Sun China	12	221 0.4×	235 1.1×	40 0.2×	81 0.7×	29 0.3×	32	566
Marta Camprubí–Rimblas Spain	13	315 0.6×	92 0.4×	60 0.4×	114 1.0×	16 0.1×	31	557
C. Tolédano France	13	156 0.3×	80 0.4×	30 0.2×	67 0.6×	94 0.8×	46	761
Zhiliang Guo China	11	124 0.2×	164 0.8×	192 1.1×	127 1.1×	16 0.1×	35	635
Abhijit Chandra India	14	261 0.5×	110 0.5×	29 0.2×	26 0.2×	33 0.3×	104	741

Countries citing papers authored by Eirini Vasarmidi

Since Specialization

Citations

This map shows the geographic impact of Eirini Vasarmidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eirini Vasarmidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eirini Vasarmidi more than expected).

Fields of papers citing papers by Eirini Vasarmidi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eirini Vasarmidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eirini Vasarmidi. The network helps show where Eirini Vasarmidi may publish in the future.

Co-authorship network of co-authors of Eirini Vasarmidi

This figure shows the co-authorship network connecting the top 25 collaborators of Eirini Vasarmidi. A scholar is included among the top collaborators of Eirini Vasarmidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eirini Vasarmidi. Eirini Vasarmidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vasarmidi, Eirini, Julie C. Worrell, Irma Mahmutovic Persson, et al.. (2025). Insights into interstitial lung disease pathogenesis. Breathe. 21(2). 240261–240261.

Vasarmidi, Eirini, et al.. (2024). Hypersensitivity Pneumonitis: Challenges of a Complex Disease. Canadian Respiratory Journal. 2024. 1–14. 5 indexed citations

Siafakas, Nikolaos M. & Eirini Vasarmidi. (2024). Risks of Artificial Intelligence (AI) in Medicine. 37(3). 1–5. 2 indexed citations

Bouloukaki, Izolde, Eliza Tsitoura, Eirini Vasarmidi, et al.. (2024). KL‑6, ET‑1 and S100A9 levels in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea. Experimental and Therapeutic Medicine. 29(1). 16–16.

Archer, Gabrielle, A. Justet, Madeleine Jaillet, et al.. (2024). FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(3). 486–498. 4 indexed citations

Galanakis, Nikolaos, et al.. (2024). Treatment challenge in a patient with massive hemoptysis: The need for superselective embolization. 37(2). 1–4.

Αντωνίου, Κατερίνα, Eirini Vasarmidi, Anne‐Marie Russell, et al.. (2022). European Respiratory Society statement on long COVID follow-up. European Respiratory Journal. 60(2). 2102174–2102174. 102 indexed citations breakdown →

Justet, A., Eirini Vasarmidi, Madeleine Jaillet, et al.. (2022). FGF19 is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 67(2). 173–187. 13 indexed citations

M’kacher, Radhia, Madeleine Jaillet, Bruno Colicchio, et al.. (2022). Lung Fibroblasts from Idiopathic Pulmonary Fibrosis Patients Harbor Short and Unstable Telomeres Leading to Chromosomal Instability. Biomedicines. 10(2). 310–310. 6 indexed citations

10.

Αντωνίου, Κατερίνα, Eliza Tsitoura, Eirini Vasarmidi, et al.. (2021). Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care. Current Opinion in Pharmacology. 57. 71–80. 8 indexed citations

11.

Vassalou, Evangelia E., Eirini Vasarmidi, Maria Bolaki, et al.. (2021). Performance of Lung Ultrasound for Monitoring Interstitial Lung Disease. Journal of Ultrasound in Medicine. 41(5). 1077–1084. 14 indexed citations

12.

Tsitoura, Eliza, Athina Trachalaki, Eirini Vasarmidi, et al.. (2021). Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality. Frontiers in Immunology. 12. 645548–645548. 22 indexed citations

13.

Trachalaki, Athina, Eliza Tsitoura, Rachele Invernizzi, et al.. (2021). Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis. Frontiers in Immunology. 12. 661811–661811. 52 indexed citations

14.

Ierodiakonou, Despo, Eirini Vasarmidi, Maria Bolaki, et al.. (2021). Case Report: Diagnosis of Myelodysplastic Syndrome in a 72-Year-Old Female With Interstitial Lung Disease. Frontiers in Medicine. 8. 673573–673573. 1 indexed citations

15.

Tsitoura, Eliza, Eirini Vasarmidi, Eleni Bibaki, et al.. (2019). Accumulation of damaged mitochondria in alveolar macrophages with reduced OXPHOS related gene expression in IPF. Respiratory Research. 20(1). 264–264. 41 indexed citations

16.

Alpantaki, Kalliopi, et al.. (2018). Herpes simplex virus type-1 infection affects the expression of extracellular matrix components in human nucleus pulposus cells. Virus Research. 259. 10–17. 5 indexed citations

17.

Margaritopoulos, George, Athina Trachalaki, Athol U. Wells, et al.. (2018). Pirfenidone improves survival in IPF: results from a real-life study. BMC Pulmonary Medicine. 18(1). 177–177. 71 indexed citations

18.

Daniil, Zoe, Ourania S. Kotsiou, Foteini Malli, et al.. (2018). Detection of mitochondrial transfer RNA (mt-tRNA) gene mutations in patients with idiopathic pulmonary fibrosis and sarcoidosis. Mitochondrion. 43. 43–52. 10 indexed citations

19.

Tsitoura, Eliza, Athol U. Wells, Konstantinos Karagiannis, et al.. (2016). MiR-185/AKT and miR-29a/Collagen 1a pathways are activated in IPF BAL cells. Oncotarget. 7(46). 74569–74581. 23 indexed citations

20.

Margaritopoulos, George, Eirini Vasarmidi, & Κατερίνα Αντωνίου. (2016). Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy. PubMed. Volume 11. 11–22. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact